Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Candesartan cilexetil - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for candesartan cilexetil and what is the scope of candesartan cilexetil patent protection?

Candesartan cilexetil
is the generic ingredient in four branded drugs marketed by Sandoz, Macleods Pharms Ltd, Astrazeneca, Apotex Inc, Mylan Labs, and Dr Reddys Labs Ltd, and is included in nine NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for candesartan cilexetil. Eleven suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: candesartan cilexetil

Drug Master File Entries: see list22
Suppliers / Packagers: see list11
Bulk Api Vendors: see list72
Clinical Trials: see list55
Patent Applications: see list3,207
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:candesartan cilexetil at DailyMed

Pharmacology for Ingredient: candesartan cilexetil

Tentative approvals for CANDESARTAN CILEXETIL

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe16MG; 12.5MGTABLET; ORAL
► Subscribe► Subscribe32MG; 25MGTABLET; ORAL
► Subscribe► Subscribe32MG; 12.5MGTABLET; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Macleods Pharms Ltd
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL204100-003Feb 27, 2015ABRXNoNo► Subscribe► Subscribe
Macleods Pharms Ltd
candesartan cilexetil
TABLET;ORAL203813-004Dec 5, 2016ABRXNoNo► Subscribe► Subscribe
candesartan cilexetil
TABLET;ORAL078702-004May 3, 2013ABRXNoNo► Subscribe► Subscribe
Apotex Inc
candesartan cilexetil
TABLET;ORAL202079-003Jan 10, 2014ABRXNoNo► Subscribe► Subscribe
Macleods Pharms Ltd
candesartan cilexetil
TABLET;ORAL203813-003Dec 5, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus